Details

Autor(en) / Beteiligte

• Seasely, Angela R
• Blanchard, Christina T
• Arora, Nitin
• Battarbee, Ashley N
• Casey, Brian M
• Dionne-Odom, Jodie
• Leal, Jr, Sixto M
• Moates, Derek B
• Sinkey, Rachel G
• Szychowski, Jeff M
• Tita, Alan T
• Subramaniam, Akila

Titel

Maternal and Perinatal Outcomes Associated With the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Ist Teil von

• Obstetrics and gynecology (New York. 1953), 2022-08, Vol.140 (2), p.262-265

Ort / Verlag

United States

Erscheinungsjahr

2022

Quelle

MEDLINE

Beschreibungen/Notizen

• Two years into the coronavirus disease 2019 (COVID-19) pandemic, we have now seen three main variant waves. We performed a retrospective cohort study of all pregnant patients with COVID-19 at our institution from March 22, 2020, to February 26, 2022, to evaluate disease severity and perinatal outcomes among the variants. Patients were categorized as pre-Delta (March 22, 2020-May 31, 2021), Delta (July 1, 2021-December 15, 2021), or Omicron (December 16, 2021- February 26, 2022) based on variant tracking from the Centers for Disease Control and Prevention and genotype sequencing at our institution. There were fewer cases of severe-critical disease (1.8% Omicron vs 13.3% pre-Delta and 24.1% Delta) and adverse perinatal outcomes during the Omicron wave compared with the pre-Delta and Delta waves.